Stay updated on Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Expands and clarifies the Phase 3 PsA trial design for upadacitinib (two periods, explicit dosing arms, long-term extension) and updates drug naming from ABT-494 to upadacitinib, while broadening data-sharing details.
    Difference
    7%
    Check dated 2025-09-13T16:59:05.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to include a new research article on the safety profile of Upadacitinib, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    1%
    Check dated 2025-09-06T14:32:35.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as new MedlinePlus related topics. Notably, the previous version's references to certain locations and topics have been removed.
    Difference
    17%
    Check dated 2025-08-30T11:20:47.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-16T04:31:14.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-08T23:51:04.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.5%
    Check dated 2025-08-01T19:24:00.000Z thumbnail image

Stay in the know with updates to Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.